POA
PFE icon

Pergamon Offshore Advisors’s Pfizer PFE Stock Holding History

Pergamon Offshore Advisors’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-36,258
Closed -$1.15M – 194
2015
Q2 		$1.15M Hold
36,258
– – 1.22% 10
2015
Q1 		$1.2M Buy
+36,258
New +$1.15M 1.16% 13

Other funds holding PFE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Pergamon Offshore Advisors's PFE Position: Q3 2015 in Review

Pergamon Offshore Advisors sold out of Pfizer (PFE) in Q3 2015, closing a stake of 36,258 shares — an estimated $1.15M sold.

Pergamon Offshore Advisors first reported a position in PFE in Q1 2015 and held it in 2 quarters. The position peaked at $1.2M in Q1 2015. 1,880 funds tracked by Wall St. Rank hold PFE as of Q3 2015.

  • Pergamon Offshore Advisors reported no remaining Pfizer position as of Q3 2015 after selling out during the quarter.
  • Pergamon Offshore Advisors sold 36,258 Pfizer shares in Q3 2015, an estimated $1.15M.
  • Pergamon Offshore Advisors first reported a position in Pfizer in Q1 2015 and held it in 2 quarters.
  • Pergamon Offshore Advisors's Pfizer position peaked at $1.2M in Q1 2015.
  • 1,880 funds tracked by Wall St. Rank held Pfizer as of Q3 2015.

Based on Pergamon Offshore Advisors's 13F filing for Q3 2015, filed 12 Nov 2015.